STRO
Sutro Biopharma
15.30$
-0.9%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Sutro Biopharma (STRO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -177 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -13 | -37 | 13 | -65 | -68 | -82 | 3.5 | -112 | -192 | -177 | |
| 5.7 | 5.0 | 4.5 | 4.8 | 4.3 | 4.8 | 5.7 | 6.8 | 7.2 | 7.3 | |
| 1.0 | 1.4 | 2.9 | 10 | 12 | 23 | 26 | 25 | 25 | 14 | |
| 1.1 | 4.5 | 3.0 | 11 | -28 | 37 | 13 | – | – | – | |
| -22 | -27 | 43 | -23 | -11 | -18 | 104 | -34 | 8.9 | -50 | |
| 4.4 | 3.3 | 1.6 | 3.5 | 7.1 | 15 | 7.9 | 4.3 | 3.1 | 1.7 | |
| 9.6 | 33 | -80 | -51 | 0.6 | -97 | -35 | -3.9 | 219 | 45 | |
| – | – | – | 0.3 | 0.3 | – | 0.5 | – | – | – | |
| 0.2 | 15 | 84 | -0.3 | -0.3 | 0.0 | -0.5 | -0.5 | – | – | |
| 15 | 15 | -5.0 | -5.0 | 15 | -9.4 | -9.4 | -13 | -4.1 | 0.0 | |
| 0.2 | 15 | 171 | -4.2 | 269 | 3.3 | 48 | 138 | 94 | 0.0 | |
| -3.4 | 10 | 103 | -120 | 202 | -176 | 17 | 22 | 121 | -132 | |
| -18 | -40 | 11 | -69 | -75 | -97 | -4.3 | -116 | -195 | -179 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.